Richard Kovacs to Survival Analysis
This is a "connection" page, showing publications Richard Kovacs has written about Survival Analysis.
Connection Strength
0.031
-
Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study. Lancet Oncol. 2020 08; 21(8):1035-1044.
Score: 0.020
-
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet. 2011 Jun 25; 377(9784):2181-92.
Score: 0.011